Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis
- PMID: 22647538
- PMCID: PMC3396789
- DOI: 10.1016/j.diagmicrobio.2012.04.008
Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis
Abstract
Because of its potentially important role in the pathogenesis of sepsis, the expression of soluble decoy receptor 3 (DcR3) was investigated in sera of sepsis patients. The serum levels of DcR3 and its tumor necrosis factor-like ligand TL1A and homologous decoy receptor OPG were quantified by ELISA. The values of DcR3 to diagnose sepsis were analyzed by receiver-operating characteristic (ROC) curves. The results showed that DcR3 was significantly elevated in sepsis compared to systemic inflammatory response syndrome (SIRS), a condition similar to sepsis but resulting from noninfectious insults. DcR3 showed superior area under the ROC curve (AUC, 0.958) compared to poor AUCs of TL1A and OPG. At a cut-off of 3.24 ng/mL, DcR3 predicted sepsis from SIRS with 96% sensitivity and 82.6% specificity. DcR3 also predicted sepsis from cancer and inflammatory bowel disease with equally excellent values. Therefore, DcR3 serum level has the potential to serve as a reliable biomarker of sepsis.
Copyright © 2012 Elsevier Inc. All rights reserved.
Figures



Similar articles
-
Diagnostic value of decoy receptor 3 combined with procalcitonin and soluble urokinase-type plasminogen activator receptor for sepsis.Cell Mol Biol Lett. 2018 May 9;23:22. doi: 10.1186/s11658-018-0087-z. eCollection 2018. Cell Mol Biol Lett. 2018. PMID: 29760745 Free PMC article.
-
Serum decoy receptor 3, a potential new biomarker for sepsis.Clin Chim Acta. 2012 Apr 11;413(7-8):744-8. doi: 10.1016/j.cca.2012.01.007. Epub 2012 Jan 16. Clin Chim Acta. 2012. PMID: 22280900
-
Increased circulating levels of tumor necrosis factor-like cytokine 1A and decoy receptor 3 correlate with SYNTAX score in patients undergoing coronary surgery.J Int Med Res. 2018 Dec;46(12):5167-5175. doi: 10.1177/0300060518793787. Epub 2018 Sep 13. J Int Med Res. 2018. PMID: 30213220 Free PMC article.
-
Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.Biochem Pharmacol. 2011 Apr 1;81(7):838-47. doi: 10.1016/j.bcp.2011.01.011. Epub 2011 Feb 2. Biochem Pharmacol. 2011. PMID: 21295012 Review.
-
The TL1A/DR3/DcR3 pathway in autoimmune rheumatic diseases.Semin Arthritis Rheum. 2015 Aug;45(1):1-8. doi: 10.1016/j.semarthrit.2015.02.007. Epub 2015 Feb 20. Semin Arthritis Rheum. 2015. PMID: 25887448 Review.
Cited by
-
Elevated Serum Levels of the Antiapoptotic Protein Decoy-Receptor 3 Are Associated with Advanced Liver Disease.Can J Gastroenterol Hepatol. 2016;2016:2637010. doi: 10.1155/2016/2637010. Epub 2016 Aug 9. Can J Gastroenterol Hepatol. 2016. PMID: 27595094 Free PMC article.
-
When Cultures Fail: Postmortem Decoy Receptor 3 (DcR3) as a Marker of Antemortem Sepsis.Acad Forensic Pathol. 2019 Mar;9(1-2):15-23. doi: 10.1177/1925362119851075. Epub 2019 Sep 6. Acad Forensic Pathol. 2019. PMID: 34394787 Free PMC article.
-
Nutritional immunomodulation of Atlantic salmon response to Renibacterium salmoninarum bacterin.Front Mol Biosci. 2022 Sep 21;9:931548. doi: 10.3389/fmolb.2022.931548. eCollection 2022. Front Mol Biosci. 2022. PMID: 36213116 Free PMC article.
-
Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions.J Biomed Sci. 2017 Jun 19;24(1):39. doi: 10.1186/s12929-017-0347-7. J Biomed Sci. 2017. PMID: 28629361 Free PMC article. Review.
-
Predictive value of decoy receptor 3 in postoperative nosocomial bacterial meningitis.Int J Mol Sci. 2014 Nov 3;15(11):19962-70. doi: 10.3390/ijms151119962. Int J Mol Sci. 2014. PMID: 25372942 Free PMC article.
References
-
- American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864–874. - PubMed
-
- Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–1310. - PubMed
-
- Calich V.L., Pina A., Felonato M., Bernardino S., Costa T.A., Loures F.V. Toll-like receptors and fungal infections: the role of TLR2, TLR4 and MyD88 in paracoccidioidomycosis. FEMS Immunol Med Microbiol. 2008;53:1–7. - PubMed
-
- Chang Y.C., Hsu T.L., Lin H.H., Chio C.C., Chiu A.W., Chen N.J. Modulation of macrophage differentiation and activation by decoy receptor 3. J Leukoc Biol. 2004;75:486–494. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical